Eran Harary
Eran Harary publishes mostly in Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health, on topics such as Schizophrenia research and treatment, Pharmaceutical studies and practices and Phosphodiesterase function and regulation.
- World rank
- #2,772,720 of 7,710,434 ranked researchers
- Rank in Israel
- #17,881 of 38,292
- Works
- 29
- Citations
- 338
- Citations per work
- 11.7
What does Eran Harary research?
Eran Harary's work is mostly in Medicine (40%), Psychology (18%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1239.7%
- Medicine1239.7%
- Everything else1032.9%
- Social Sciences517.8%
- Psychology517.8%
- Life Sciences39.6%
- 1Psychiatry and Mental health33% of their works
- 2Clinical Psychology12% of their works
- 3Pediatrics, Perinatology and Child Health7% of their works
- 4Molecular Biology6% of their works
- 5Experimental and Cognitive Psychology6% of their works
- 6Cellular and Molecular Neuroscience4% of their works
Research topics
- Schizophrenia research and treatment
- Pharmaceutical studies and practices
- Phosphodiesterase function and regulation
- Dementia and Cognitive Impairment Research
- Attention Deficit Hyperactivity Disorder
- Obsessive-Compulsive Spectrum Disorders
- Healthcare Decision-Making and Restraints
- Genetic Neurodegenerative Diseases
Which keywords describe Eran Harary's research?
The keywords of their largest research topics: Antipsychotic Drugs, Neurocognitive Deficits, Neuroimaging, Off-Label Drug Use, Pediatric Pharmacokinetics, Alzheimer's Disease, cAMP Signaling and Cyclic Nucleotide Phosphodiesterases.
- Huntington's Disease
- Psychiatric Treatment
- Informed Consent
- ADHD
- Mild Cognitive Impairment
- Alzheimer's Disease
- Off-Label Drug Use
- Neurocognitive Deficits
- Antipsychotic Drugs
- Neuroimaging
- Pediatric Pharmacokinetics
- Cyclic Nucleotide Phosphodiesterases
- cAMP Signaling
- Attention-Deficit/Hyperactivity Disorder
- Obsessive-Compulsive Disorder
- Tourette Syndrome
- Protein Aggregation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Antipsychotic Drugs141 topic
- Neurocognitive Deficits141 topic
- Neuroimaging72 topics
- Off-Label Drug Use51 topic
- Pediatric Pharmacokinetics51 topic
- Alzheimer's Disease41 topic
- Cyclic Nucleotide Phosphodiesterases41 topic
- Mild Cognitive Impairment41 topic
- cAMP Signaling41 topic
- ADHD31 topic
- Attention-Deficit/Hyperactivity Disorder31 topic
- Informed Consent31 topic
- Obsessive-Compulsive Disorder31 topic
- Psychiatric Treatment31 topic
- Tourette Syndrome31 topic
- Huntington's Disease21 topic
- Protein Aggregation21 topic
Where does Eran Harary work?
Eran Harary's main affiliation in the publication record is Teva Pharmaceuticals (Israel), Israel.
How many publications and citations does Eran Harary have?
OpenAlex counts 29 works and 338 citations for Eran Harary, an h-index of 10, ranking #2,772,720 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Eran Harary. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.